Mainstay Medical Begins Clinical Trial of ReActiv8® for People with Chronic Low Back Pain

Mainstay Medical today announced that it has secured approval from Ethics Committees in Australia to start a clinical trial of ReActiv8, its innovative implantable neurostimulation device for the treatment of people with Chronic Low Back Pain .



from Content Keyword RSS http://ift.tt/1fZLwEx

via IFTTT